Date updated:06-09-2007
High flyers in both alternative energy and biotechs and my all time favorite nano stock - NVEC

-
ALDN
Aldn - $0.00
- N/A
- $N/A
ALDN, from a technology perspective continually receives awards in data security - and technically from a chart perspective it looks like it wants to run

-
ENER
Energy Conversion - $10.93
- 0.00%
- $N/A
Alternative Energy Play - great sector now and spin off of Cobasys division should give it a nice pop

-
OXBDF.PK
Oxford Biomedical - $0.155
- 0.00%
- $N/A
Biomedical with very hot cancer vaccine (TroVax potential wide range of tumours, including renal, colorectal, lung, breast and prostrate cancer. It is currently in late stage trials as a treatment for kidney cancer and this is expected to go to market by 2009. Sanofi is to develop the vaccine to treat colorectal cancer.... And partnered with "A" list partners: Sanofi-Aventis and the targeted antibody therapy collaboration with Wyeth, Arius Research, Intervet, MolMed, Sigma-Aldrich, Viragen, Virxsys and Wyeth. and licence agreements with Biogen Idec, GlaxoSmithKline, Merck & Co, Pfizer.

-
NVEC
Nve Corporation - $39.61
- +3.91%
- $38.46
Making great profits and showing accelerated growth w/o MRAM and has moved beyond the MRAM story into a viable, profitable company with accelerated revenue growth. If MRAM ever comes about it will be the frosting on the cake.

-
EXEL
Exelixis - $7.05
- +3.68%
- $7.03
great pipeline and partnerships - recommended by Motley Fool "rule breakers"

-
HTE
Harvest Energy Tr - $9.32
- +1.75%
- $9.31
my favorite Canadian Oil Trust -

-
RIG
Transocean Ltd - $88.15
- +3.22%
- $87.70
Love offshore drillers

-
BDSI
Biodelivery Scien - $4.16
- 0.00%
- $N/A
"April 25, 2007 announcement of statistically significant results with BEMA(TM) Fentanyl in treating cancer patients with breakthrough pain in the company's Phase III efficacy clinical trial. BDSI plans to include today's study results, the efficacy trial results and other materials in its planned New Drug Application (NDA) to the FDA for BEMA(TM) Fentanyl. The NDA submission is expected during the third quarter of 2007." Holding for 1-2 years BDSI will really take off - $45-$65 range given $250M conservative sales projections * 2-4 price to sales ratio / shares outstanding
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. Charlie Munger
- 5. Calamos Advisors
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » Albo's First Portfolio
- » Fundsonly Portfolio 1
- » rk00005
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 9, 2009 Financial-Services Bull: Barron’s talks with Anton Schutz, portfolio manager at the Burnham Financial Industries Fund (BURFX)...
By Jonas Elmerraji Posted on Nov. 9, 2009 Last week brought investors a welcome return to gains as the S&P 500 pushed up 3.2% over the course of the last five trading d...
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more
Here are some of the largest % gainers from Nov. 2, 2009. more
Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more













Comments not available